HER2 Support Group Forums - View Single Post - Speaking of tumor markers: Osteopontin-C

Hopeful · 11-06-2007, 08:10 AM

Grace,

Thanks for posting this. I am confused about one statement:

“If we know that this molecule is not present in a patient with breast cancer, it’s more likely that we can treat them with conservative therapy rather than breast surgery, hormone therapy or chemotherapy because we know it’s less likely to metastasize,” he adds. “On the other hand, if we know that a patient has this molecule early in their diagnosis, we can treat it more aggressively because we know their cancer is likely to become invasive.”

This sounds like he is talking about DCIS, while the beginning of the article sounds like it is talking about invasive bc and metastasis. Wonder what they mean it to apply to?

Hopeful

11-06-2007, 08:10 AM	#2
Hopeful Senior Member Join Date: Aug 2006 Posts: 3,380	Grace, Thanks for posting this. I am confused about one statement: “If we know that this molecule is not present in a patient with breast cancer, it’s more likely that we can treat them with conservative therapy rather than breast surgery, hormone therapy or chemotherapy because we know it’s less likely to metastasize,” he adds. “On the other hand, if we know that a patient has this molecule early in their diagnosis, we can treat it more aggressively because we know their cancer is likely to become invasive.” This sounds like he is talking about DCIS, while the beginning of the article sounds like it is talking about invasive bc and metastasis. Wonder what they mean it to apply to? Hopeful